Investigating the optimal size of anticancer nanomedicine L Tang, X Yang, Q Yin, K Cai, H Wang, I Chaudhury, C Yao, Q Zhou, ... Proceedings of the National Academy of Sciences 111 (43), 15344-15349, 2014 | 540 | 2014 |
Nonporous silica nanoparticles for nanomedicine application L Tang, J Cheng Nano today 8 (3), 290-312, 2013 | 481 | 2013 |
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery L Tang, Y Zheng, MB Melo, L Mabardi, AP Castaño, YQ Xie, N Li, ... Nature biotechnology 36 (8), 707-716, 2018 | 415 | 2018 |
Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions A Mishra, GH Lai, NW Schmidt, VZ Sun, AR Rodriguez, R Tong, L Tang, ... Proceedings of the National Academy of Sciences 108 (41), 16883-16888, 2011 | 337 | 2011 |
Selective in vivo metabolic cell-labeling-mediated cancer targeting H Wang, R Wang, K Cai, H He, Y Liu, J Yen, Z Wang, M Xu, Y Sun, ... Nature chemical biology 13 (4), 415-424, 2017 | 231 | 2017 |
Synthesis and Biological Response of Size-Specific, Monodisperse Drug–Silica Nanoconjugates L Tang, TM Fan, LB Borst, J Cheng ACS nano 6 (5), 3954, 2012 | 199 | 2012 |
Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion YR Yu, H Imrichova, H Wang, T Chao, Z Xiao, M Gao, M Rincon-Restrepo, ... Nature Immunology 21 (12), 1540-1551, 2020 | 192 | 2020 |
Smart chemistry in polymeric nanomedicine R Tong, L Tang, L Ma, C Tu, R Baumgartner, J Cheng Chemical Society Reviews 43 (20), 6982-7012, 2014 | 185 | 2014 |
Selective delivery of an anticancer drug with aptamer-functionalized liposomes to breast cancer cells in vitro and in vivo H Xing, L Tang, X Yang, K Hwang, W Wang, Q Yin, NY Wong, ... Journal of Materials Chemistry B 1 (39), 5288-5297, 2013 | 180 | 2013 |
Redox-Responsive, Core-Cross-Linked Micelles Capable of On-Demand, Concurrent Drug Release and Structure Disassembly H Wang, L Tang, C Tu, Z Song, Q Yin, L Yin, Z Zhang, J Cheng Biomacromolecules 14 (10), 3706-3712, 2013 | 171 | 2013 |
Size-dependent tumor penetration and in vivo efficacy of monodisperse drug-silica nanoconjugates L Tang, NP Gabrielson, TM Fan, J Cheng Molecular pharmaceutics, 2013 | 165 | 2013 |
Biomaterial strategies for immunomodulation NA Hotaling, L Tang, DJ Irvine, JE Babensee Annual review of biomedical engineering 17, 317, 2015 | 148 | 2015 |
Chain‐Shattering Polymeric Therapeutics with On‐Demand Drug‐Release Capability Y Zhang, Q Yin, L Yin, L Ma, L Tang, J Cheng Angewandte Chemie International Edition 52 (25), 6435-6439, 2013 | 133 | 2013 |
Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy Y Guo, K Lei, L Tang Frontiers in Immunology 9, 1499, 2018 | 127 | 2018 |
Enhancing adoptive cell therapy of cancer through targeted delivery of small-molecule immunomodulators to internalizing or noninternalizing receptors Y Zheng, L Tang, L Mabardi, S Kumari, DJ Irvine ACS nano 11 (3), 3089-3100, 2017 | 117 | 2017 |
Aptamer‐Functionalized, Ultra‐Small, Monodisperse Silica Nanoconjugates for Targeted Dual‐Modal Imaging of Lymph Nodes with Metastatic Tumors L Tang, X Yang, LW Dobrucki, I Chaudhury, Q Yin, C Yao, S Lezmi, ... Angewandte Chemie 124 (51), 12893-12898, 2012 | 116 | 2012 |
High-throughput quantitation of inorganic nanoparticle biodistribution at the single-cell level using mass cytometry YSS Yang, PU Atukorale, KD Moynihan, A Bekdemir, K Rakhra, L Tang, ... Nature communications 8 (1), 1-11, 2017 | 107 | 2017 |
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity Y Guo, YQ Xie, M Gao, Y Zhao, F Franco, M Wenes, I Siddiqui, ... Nature Immunology 22 (6), 746-756, 2021 | 106 | 2021 |
The therapeutic efficacy of camptothecin-encapsulated supramolecular nanoparticles KJ Chen, L Tang, MA Garcia, H Wang, H Lu, WY Lin, S Hou, Q Yin, ... Biomaterials, 2011 | 96 | 2011 |
Polylactide-cyclosporin A nanoparticles for targeted immunosuppression J Azzi, L Tang, R Moore, R Tong, N El Haddad, T Akiyoshi, B Mfarrej, ... The FASEB Journal 24 (10), 3927-3938, 2010 | 96 | 2010 |